Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line

Life Sciences

Volumn 78, Issue 23, 2006, Pages 2716-2723

  Radice, Sonia ^a   Chiesara, Enzo ^a   Frigerio, Silvia ^a   Fumagalli, Roberta ^a   Parolaro, Daniela ^b   Rubino, Tiziana ^b   Marabini, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DBSF   (Italy)

Author keywords

c Neu receptor; Estrogen receptor; ICI 182780; MAPK; MCF 7; Oxygen free radicals; Procymidone

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA TOCOPHEROL; ANTIBODY; ANTIESTROGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FULVESTRANT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROCYMIDONE; PROTEIN PS2; REACTIVE OXYGEN METABOLITE; BICYCLO COMPOUND; ENZYME INHIBITOR; ESTROGEN; FLAVONOID; FUNGICIDE; GROWTH PROMOTOR; TFF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL STIMULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ESTROGEN ACTIVITY; EVALUATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RECEPTOR BINDING; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; ENZYME INDUCTION; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ONCORHYNCHUS MYKISS;

ALPHA-TOCOPHEROL; BICYCLO COMPOUNDS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG COMBINATIONS; ENZYME INDUCTION; ENZYME INHIBITORS; ESTROGENS, NON-STEROIDAL; FEMALE; FLAVONOIDS; FUNGICIDES, INDUSTRIAL; GROWTH SUBSTANCES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TUMOR SUPPRESSOR PROTEINS;

EID: 33646841806     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.10.008     Document Type: Article

References (69)

1. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., and Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. Journal of Biological Chemistry 271 (1996) 16586-16590
2. Allen R.G., and Tressini M. Oxidative stress and gene regulation. Free Radical Biology and Medicine 28 (2000) 463-499
3. Andersen H.R., Vinggaard A.M., Rasmussen T.H., Gjermandsen I.M., and Bonefeld-Jørgensen. Effect of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicology and Applied Pharmacology 179 (2002) 1-12
4. Barth A., Landmann G., Liepold K., Zapf H., Mueller D., Karge E., and Klinger W. Influence of oestrogens on formation of reactive oxygen species in liver microsomes of differently aged male Wistar rats. Experimental Toxicology and Pathology 51 (1999) 282-288
5. Bolton J.L. Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology 177 (2002) 55-65
6. Bunone G., Briand P.A., Miksicek R.J., and Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO Journal 15 (1996) 2174-2183
7. Chen H., Xiao J., Hu G., Zhou J., Xiao H., and Wang X. Estrogenicity of organophosphorus and pyrethroid pesticides. Journal of Toxicology and Environmental Health Part A 65 (2002) 1419-1435
8. Clerk A., Fuller S.J., Michael A., and Sugden P.H. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen activated protein kinases) in perfused rat hearts by oxidative and other stresses. Journal of Biological Chemistry 273 (1998) 7228-7234
9. Clerk A., Michael A., and Sugden P.H. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes. Biochemical Journal 333 (1998) 581-589
10. Dees C., Askari M., and Foster J.S. DDT mimics estradiol stimulation of breast cancer cells to enter the cell cycle. Molecular Carcinogenesis 18 (1997) 107-114
11. Di Domenico M., Castoria G., Bilancio A., Migliaccio A., and Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Research 56 (1996) 4516-4521
12. Dornstauder E., Jisa E., Unterrieder I., Krenn L., Kubelka W., and Jungbauer A. Estrogenic activity of two standardized red clover extracts (Menoflavon®) intended for large scale use in hormone replacement therapy. Journal of Steroid Biochemistry and Molecular Biology 78 (2001) 67-75
13. Dröge W. Free radicals in the physiological control of cell function. Physiological Review 82 (2002) 47-95
14. Edlich W., and Lyr H. Target Sites of Fungicides with Primary Effects on Lipid Peroxidation (1992), Marcell Dekker, New York 53-68
15. Enan E., and Matsamura F. Activation of c-Neu tyrosine kinase by o,p′-DDT and β-HCH in cell-free and intact cell preparations from MCF-7 human breast cancer cells. Journal of Biochemistry and Molecular Toxicology 12 (1998) 83-90
16. Endoh H., Sasaki H., Maruyama K., Takeyama K., Waga I., Shimizu T., Kato S., and Kawashima H. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochemical and Biophysical Research Communication 235 (1997) 99-102
17. Gagné F., and Blaise C. Estrogenic properties of municipal and industrial wastewater evaluated with a rapid and sensitive chemoluminescent in situ hybridization assay in rainbow trout hepatocytes. Aquatic Toxicology 44 (1998) 83-91
18. Goksøyr A. A semi-quantitative cytochrome P4501A1 ELISA: a simple method for studying the monooxygenase induction response in environmental monitoring and ecotoxicological testing of fish. Science of Total Environment 101 (1991) 255-262
19. Gray Jr. L.E., Ostby J., Cooper R.L., and Kelce W.R. The estrogenic and antiandrogenic pesticide methoxychlor alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicology and Industrial Health 15 (1999) 37-47
20. 2. Journal of Biological Chemistry 271 (1996) 4138-4142
21. Hatakeyama M., and Matsumura F. Correlation between the activation of Neu tyrosine kinase and promotion of foci formation induced by selected organochlorine compounds in MCF-7 model system. Journal of Biochemistry and Molecular Toxicology 13 (1999) 296-302
22. Hatakeyama M., Tessier D.M., Dunlap D.Y., Zou E., and Matsumura F. Estrogenic action of β-HCH through activation of c-Neu in MCF-7 breast carcinoma cells. Environmental Toxicology and Pharmacology 11 (2002) 27-38
23. Hehner S.P., Breitkreutz R., Shubinsky G., Unsoeld H., Schulze-Osthoff K., Schmitz M.L., and Dröge W. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. Journal of Immunology 165 (2000) 4319-4328
24. Improta-Brears T., Whorton A.R., Codazzi F., York Y.D., Meyer T., and McDonnell D.P. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 4686-4691
25. Jorgensen E.C.B., Autrup H., and Hansen J.C. Effect of toxaphene on estrogen receptor function in human breast cancer cells. Carcinogenesis 18 (1997) 1651-1654
26. Kang H.I.I., Kim H.S., Shin J., Kim T.S., Moon H.J., Kim I.Y., Choi S.K., Kil K.S., Park Y.I., Dong M.S., and Han S.Y. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p,p′-DDE in rodent 10-day Hershberger assay. Toxicology 199 (2004) 145-159
27. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashiwa H., Metzger D., and Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1499
28. Keshamouni V.G., Mattingly R.R., and Reddy K.B. Mechanism of 17-β-estradiol-induced Erk1/2 activation in breast cancer cells. Journal of Biological Chemistry 277 (2002) 22558-22565
29. Kim M.H., Cho H.S., Jung M., Hong M.H., Lee S.K., Shin B.A., Ahn B.W., and Jung Y.D. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. International Journal of Oncology 26 (2005) 1669-1674
30. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecological disorders. Advances in Therapeutics 15 (1998) 45-53
31. Lobenhofer E.K., Huper G., Iglehart J.D., and Marks J.R. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth and Differentiation 11 (2000) 99-110
32. Lott H.M., and Barker S.A. Matrix solid-phase dispersion extraction and gas chromatography screening of 14 chlorinated pesticides in oyster Crassostrea virginica. Journal of Association of Analytical Chemistry 76 (1993) 67-75
33. Lu Q., Ebling H., Mittler J., Baur W.E., and Karas R.H. MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor α. FEBS Letters 516 (2002) 1-8
34. Maggiolini M., Statti G., Vivacqua A., Gabriele S., Rago V., Loizzo M., Menichini F., and Amdò S. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF-7 breast cancer cells. Journal of Steroid Biochemistry and Molecular Biology 82 (2002) 315-322
35. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO Journal 15 (1996) 1292-1300
36. Mukhin Y.V., Garnovskaya M.N., Collinsworth G., Grewal J.S., Pedengrass D., Nagai T., Pickney S., Greene E.L., and Raymond R.J. 5-hydroxytriptamine 1A receptor/Gibetagamma stimulates mitogen activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of src in Chinese hamster ovary fibroblasts. Biochemical Journal 347 (2000) 61-67
37. Mydlo J.H., Kral J.G., Volpe M., Axotis C., Macchia R.J., and Pertshu K.L.P. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer. Preliminary results and therapeutic implications. European Urology 34 (1998) 426-434
38. Obata T. Environmental estrogen-like chemicals and hydroxyl radicals induced by PTP in the striatum: a review. Neurochemical Research 27 (2002) 423-431
39. Oh S.M., and Chung K.H. Estrogenic activities of Ginkgo biloba extracts. Life Science 74 (2004) 1325-1335
40. Okubo T., Yokoyama Y., Kano K., and Kano I. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ER α and PR. Food and Chemical Toxicology 39 (2001) 1225-1232
41. Olsen C.M., Meussen-Elholm E.T.M., Holme J.A., and Hongslo J.K. Brominated phenols: characterization of estrogen-like activity in the human breast cancer cell-line MCF-7. Toxicology Letters 129 (2002) 55-63
42. Otsby J., Kelce W.R., Lambright C., Wolf C.J., Mann P., and Gray L.E. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicology and Industrial Health 15 (1999) 80-93
43. Pages G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., and Pouyssegur J. Mitogen-activated protein kinase p42 mapk and p44 mapk are required for fibroblast proliferation. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 8319-8323
44. Radice S., Marabini L., Gervasoni M., Ferraris M., and Chiesara E. Adaptation to oxidative stress: effect of vinclozolin and iprodione on the HepG2 cell line. Toxicology 129 (1998) 183-191
45. Radice S., Ferraris M., Marabini L., Grande S., and Chiesara E. Effect of iprodione, a dicarboximide fungicide, on primary cultured trout hepatocytes (Oncorhynchus mykiss). Aquatic Toxicology 54 (2001) 51-58
46. Radice S., Ferraris M., Marabini L., and Chiesara E. Estrogenic activity of procymidone in primary cultured trout hepatocytes (Oncorhynchus mykiss). Toxicology in Vitro 16 (2002) 475-480
47. Radice S., Fumagalli R., Chiesara E., Ferraris M., Frigerio S., and Marabini L. Estrogenic activity of procymidone in rainbow trout (Oncorhynchus mykiss) hepatocytes: a possible mechanism of action. Chemico-Biological Interactions 147 (2004) 185-193
48. Ramamoorthy K., Vyhlidal C., Wang F., Chen I.C., Safe S., McDonnel D.P., Leonard L.S., and Gaido K.W. Additive estrogenic activities of a binary mixture of 2′,4′,6′,-trichloro- and 2′,3′,4′,5′-tetrachloro-4-biphenylol. Toxicology and Applied Pharmacology 147 (1997) 93-100
49. Ramanathan L., and Gray W.G. Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell. Toxicology and Applied Pharmacology 191 (2003) 107-117
50. Ren L., Marquardt M.A., and Lech J.J. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Chemico-Biological Interactions 104 (1997) 55-64
51. Riby J.E., Grace H.F.G., Firestone G.L., and Bjeldanes L.F. Ligand-independent activation of estrogen receptor function by 3,3′-diindolylmethane in human breast cancer cells. Biochemical Pharmacology 60 (2000) 167-177
52. Schiller C.D. Assessment of viability of hepatocytes in suspension using the MTT assay. Toxicology In Vitro 6 (1992) 575-578
53. Sewack G.F., and Hansen U. Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter. Journal of Biological Chemistry 272 (1997) 31118-31129
54. Singh M., Setalo Jr. G., Guan X., Warren M., and Toran-Allerand C.D. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signalling pathways. Journal of Neuroscience 19 (1999) 1179-1188
55. Song R.X.D., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., and Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Molecular Endocrinology 16 (2002) 116-127
56. Soto A.M., Chung K.L., and Sonnenschein C. The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environmental Health Perspective 102 (1994) 380-383
57. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olean N., and Olea-Serrano F. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environmental Health Perspective 103 (1995) 113-122
58. Sumpter J.P. Feminized responses in fish to environmental estrogens. Toxicology Letters 82 (1995) 737-742
59. Tapiero H., Nguyen Ba G., and Tew K.D. Estrogen and environmental estrogens. Biomedicine and Pharmacotherapy 56 (2002) 36-44
60. Thibodeau P.A., Bissonnette N., Bedard S.K., Hunting D., and Paquette B. Induction by estrogens of methotrexate resistance in MCF-7 breast cancer cells. Carcinogenesis 19 (1998) 1542-1545
61. Tremblay A., Tremblay G.B., Labrie F., and Giguère V. Ligand-independent recruitment of SRC-1 to estrogen receptor through phosphorylation of activation function AF-1. Molecular Cell 3 (1999) 513-519
62. Ushio-Fuka M., Alexander R.W., Akers M., and Griendling K.K. p38 MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. Journal of Biological Chemistry 273 (1998) 15022-15029
63. Vanni A., Gamberini R., Calabria A., and Pellegrino V. Determination of presence of fungicides by their common metabolite, 3,5-DCA, in compost. Chemosphere 41 (2000) 453-458
64. Vanni A., Gamberini R., Calabria A., and Nappi P. Determination and identification of metabolites of the fungicide iprodione and procymidone in compost. Chemosphere 41 (2000) 1431-1439
65. Vinggaard A.M., Breinholt V., and Larsen J.C. Screening of selected pesticides for oestrogen receptor activation in vitro. Food and Additives and Contaminants 16 (1999) 533-542
66. Wiechen K., and Dietel M. c-erbB-2 anti-sense phosphorothioate oligodeoxynucleotides inhibit growth and serum-induced cell spreading of p185 c-erbB-2-overexpressing ovarian carcinoma cells. International Journal of Cancer 63 (1995) 604-608
67. Yan Y., Haas J.P., Sgagias K.M., and Cowan K.H. BRCA1-induced apoptosis involves inactivation of ERK1/2 activities. Journal of Biological Chemistry 277 (2002) 33422-33430
68. Yue W., Wang J.P., Conaway M., Masamura S., Li Y., and Santen R.J. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol. Endocrinology 143 (2002) 3221-3229
69. Zou E., Hatakeyama M., and Matsumura F. Foci formation of MCF-7 cells as an in vitro screening method for estrogenic chemicals. Environmental Toxicology and Pharmacology 11 (2002) 71-77